Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Zomig - Treatment of Acute Migraine Headache in Adolescents

ClinicalTrials.gov ID: NCT01211145

Public ClinicalTrials.gov record NCT01211145. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate if Zomig® Nasal Spray will help children (age 12-17 years) with migraine headaches feel better. This will be done by comparing 3 different doses of Zomig Nasal Spray with placebo nasal spray (inactive treatment).

Study identification

NCT ID
NCT01211145
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
AstraZeneca
Industry
Enrollment
1,653 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2010 (Type not available)
Primary completion
Oct 2013 (Actual)
Completion
Oct 2013 (Actual)
Last update posted
May 18, 2016

2010 – 2013

United States locations

U.S. sites
46
U.S. states
21
U.S. cities
46
Facility City State ZIP Site status
Research Site Phoenix Arizona — —
Research Site Fresno California — —
Research Site Fullerton California — —
Research Site Newport Beach California — —
Research Site Sacramento California — —
Research Site San Diego California — —
Research Site San Francisco California — —
Research Site Centennial Colorado — —
Research Site Colorado Springs Colorado — —
Research Site Thornton Colorado — —
Research Site Fairfield Connecticut — —
Research Site Boca Raton Florida — —
Research Site Hallandale Florida — —
Research Site Miami Florida — —
Research Site Miami Lakes Florida — —
Research Site North Palm Beach Florida — —
Research Site Orlando Florida — —
Research Site Tampa Florida — —
Research Site West Palm Beach Florida — —
Research Site Owensboro Kentucky — —
Research Site Worcester Massachusetts — —
Research Site Ann Arbor Michigan — —
Research Site Plymouth Minnesota — —
Research Site Ocean Springs Mississippi — —
Research Site Olive Branch Mississippi — —
Research Site Columbia Missouri — —
Research Site Springfield Missouri — —
Research Site St Louis Missouri — —
Research Site The Bronx New York — —
Research Site Cary North Carolina — —
Research Site Hickory North Carolina — —
Research Site Raleigh North Carolina — —
Research Site Akron Ohio — —
Research Site Cleveland Ohio — —
Research Site Toledo Ohio — —
Research Site Oklahoma City Oklahoma — —
Research Site Indiana Pennsylvania — —
Research Site Jackson Tennessee — —
Research Site Nashville Tennessee — —
Research Site San Antonio Texas — —
Research Site Spring Texas — —
Research Site Salt Lake City Utah — —
Research Site South Jordan Utah — —
Research Site Charlottesville Virginia — —
Research Site Norfolk Virginia — —
Research Site Middleton Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01211145, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01211145 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →